The purpose of this research is to determine which medication provides better and safer conditions for placing the breathing tube in adult patients who need tracheal intubation during surgery. The study will look at how well each medication works and any possible side effects that may occur during or after the procedure.

During the study, patients will receive either remifentanil or rocuronium before the breathing tube is inserted. Doctors will monitor patients for any complications that might occur within 24 hours after the procedure, including effects on breathing, heart function, or discomfort in the throat. The medication doses are carefully calculated based on each patient’s weight, with remifentanil given at up to 4 micrograms per kilogram and rocuronium at up to 0.6 milligrams per kilogram.

The purpose of this study is to investigate how long it takes and how well rapid sequence emergence from general anesthesia works, which means bringing someone quickly out of the sleep-like state caused by anesthesia. The study will measure several things during this process, with the main focus being on how long it takes for spontaneous breathing to return, meaning when the person starts breathing on their own again without help. Other measurements will include the time it takes for the person to open their eyes, when reflexes like swallowing and coughing come back, breathing patterns including oxygen levels and breathing rate, heart rate and blood pressure, brain activity levels, the depth of muscle relaxation, and the total time needed to become fully awake as before the anesthesia was given.

During the study, healthy volunteers will receive general anesthesia using the combination of medications mentioned above. The medications will be given through an injection into a vein. After the anesthesia is established, the reversal medications will be administered to bring the volunteers out of anesthesia in a controlled manner. Throughout this process, various measurements will be taken to track how quickly and smoothly the volunteers wake up from the anesthesia and return to their normal state.

The purpose of the study is to analyze how often sugammadex is used, with and without the help of a device called the TetraGraph system. This system helps monitor the level of muscle relaxation during surgery. The study will observe children aged between 2 and 16 years who are receiving general anesthesia and a non-depolarizing muscle relaxant, like rocuronium bromide. The trial will compare the use of sugammadex in different scenarios to understand its effectiveness and safety.

Throughout the study, researchers will look at various factors, such as the time it takes to remove the breathing tube after surgery, any breathing problems that occur, and the overall quality of recovery. They will also assess the reliability of using the TetraGraph system in children and monitor for any side effects from the medications or the monitoring system. The study aims to provide valuable insights into the best practices for using these medications and monitoring systems in pediatric anesthesia.

The research aims to find out how different ways of delivering oxygen to the non-operating side of the lung during surgery might affect recovery and complications afterward. The study will use three different techniques of giving oxygen to the lung that is not being operated on while the patient is under anesthesia. During the surgery, one lung is temporarily not used for breathing, which is called one-lung ventilation.

Patients who participate in this study will receive one of three different methods of oxygen delivery during their surgery. The medical team will monitor various aspects of recovery after surgery, including how well patients breathe, their overall recovery, and how long they need to stay in the hospital. The study will also look at certain substances in the blood and lung fluid that can show how the body responds to the surgery.

Participants in the study will receive either Esketamine Hydrochloride or Sodium Chloride through an infusion, which is a method of delivering medication directly into the bloodstream. The treatment will last for a maximum of 14 days. During this time, researchers will monitor the patients to see how often these brain activities occur and to check for any side effects or reactions to the treatment. The study aims to understand if Esketamine Hydrochloride can help patients whose brain activities continue despite other treatments.

After the treatment period, the study will continue to follow up with participants to assess their recovery and overall health outcomes. This will include evaluating their functional abilities six months after the treatment using standard scales like the modified Rankin Scale and the Glasgow Outcome Scale-Extended. The results of this study could provide valuable insights into new treatment options for individuals with severe brain injuries.

The main purpose of the study is to find out how often muscle relaxation returns after it has been reversed with neostigmine. This is important because sometimes, even after the medication is given to reverse the muscle relaxation, the muscles might not fully regain their normal function right away. The study will monitor patients who are undergoing general anesthesia to see how their muscles respond after receiving the reversal medication.

Participants in the study will receive the medication through an intravenous infusion, which means it will be delivered directly into the bloodstream. The study will observe the effects of the medication over a short period to gather information on how well it works in preventing the reappearance of muscle relaxation. This research aims to improve the safety and effectiveness of reversing muscle relaxation during surgeries.

The purpose of the study is to determine if adjusting the oxygen levels during surgery can improve the levels of oxygen in the blood after surgery. Participants will be randomly assigned to receive either the goal-directed low oxygen concentration or the routine fixed concentration during their surgery. The study will monitor the participants’ recovery, including their oxygen levels, lung function, and overall recovery after surgery.

Throughout the study, various aspects of the participants’ health will be assessed, such as their oxygen levels on the second day after surgery and three months later, as well as their recovery from surgery. The study will also look at factors like the length of hospital stay and any infections at the surgical site. The trial aims to provide insights into whether adjusting oxygen levels during surgery can lead to better outcomes for patients.

The purpose of the study is to evaluate how Opioid-Free Anesthesia affects the oxygen levels in the blood during the first six hours after surgery, compared to conventional anesthesia that includes opioids. This is measured by looking at the Arterial Oxygen Pressure/Inspired Fraction of Oxygen (PaO2/FiO2) ratio, which is a way to assess how well the lungs are working to get oxygen into the blood.

Participants in the study will receive either the Opioid-Free Anesthesia with Ketamine Hydrochloride or a conventional anesthesia. The study will monitor the patients’ oxygen levels and other health indicators during and after the surgery to gather data on the effectiveness and safety of the Opioid-Free Anesthesia approach. The trial aims to provide insights that could improve anesthesia practices for patients undergoing bariatric surgery.

Participants in the study will receive either Cipepofol or Propofol through an intravenous injection, which means the medication is given directly into a vein. The study aims to determine if Cipepofol can successfully induce anesthesia with minimal additional doses and without the need for other medications to help. The trial will also monitor for any pain at the injection site and ensure that the anesthesia is maintained at the right level without causing significant heart or breathing problems shortly after the medication is given.

Other medications involved in the study include Midazolam, Fentanyl, Sevoflurane, Rocuronium Bromide, and Dobutamine, which are used in various ways to support anesthesia and patient care during surgery. The study is designed to be double-blinded, meaning neither the participants nor the researchers know who is receiving which medication, to ensure unbiased results. The goal is to provide a safe and effective option for anesthesia in surgical procedures.

During the study, children will receive either the standard dose of sevoflurane or the combination of low-dose sevoflurane, dexmedetomidine hydrochloride, and remifentanil while they are under anesthesia for their surgery. The researchers will then assess the children’s cognitive development at the age of 3 using a test called the Wechsler Preschool and Primary School Intelligence Scale, which measures intelligence. The study aims to see if the combination of drugs leads to better outcomes in terms of the children’s overall cognitive function compared to the standard treatment.

The trial will also monitor other aspects such as language skills, attention, memory, and behavior, as well as the safety of the anesthesia methods used. This includes checking for any side effects or complications during and after the surgery. The study is expected to provide valuable information on how different anesthesia methods might impact the long-term development of young children who need surgery.

During the study, children will receive one of the medications or the placebo before their surgery. Researchers will then observe and record various aspects of the children’s experiences, such as their level of anxiety, any changes in heart rate or blood pressure, pain after the surgery, and how quickly they recover from anesthesia. The study will also look at whether the medications affect memory, behavior, and overall quality of life after the surgery. The main focus is on the children’s self-reported experiences 24 hours after the surgery or before they leave the hospital if they are outpatients.

The trial aims to provide valuable insights into how these medications can improve the surgical experience for children by reducing anxiety and other negative effects associated with surgery and anesthesia. By understanding these effects, healthcare providers can make better-informed decisions about premedication for children undergoing surgery, potentially leading to improved outcomes and comfort for young patients.